IFNB1 and viral infectious disease: On the other hand, antiviral treatment using IFN-β or IFN-α improves cardiac function in patients with persistent virus infection [30, 31] which is in line with the finding that an IFN-β neutralizing antibody increased virus replication in cardiomyocytes [10].